Cambridge Investment Research Advisors, Inc. Nrx Pharmaceuticals Inc Wt Exp Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$0.13 - $0.97 $1,300 - $9,700	-10,000 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.89 - $2.26 $17,310 - $43,956	-19,450 Reduced 66.04%	10,000 $0
Q4 2021 Feb 03, 2022	BUY	$1.74 - $5.44 $21,715 - $67,891	12,480 Added 73.54%	29,450 $0
Q3 2021 Nov 02, 2021	BUY	$3.2 - $14.75 $54,304 - $250,307	16,970 New	16,970 $0

Others Institutions Holding NRXPW

# of Institutions

Shares Held

122K

Call Options Held

Put Options Held

Truist Financial Corp

39K
Shares

$1,948
0.0% of portfolio
Virtu Financial LLC New York, NY

34.7K
Shares

$1,734
0.0% of portfolio
Two Sigma Securities, LLC New York, NY

17.4K
Shares

$870
0.0% of portfolio
Wolverine Asset Management LLC

15.4K
Shares

$769
0.0% of portfolio
Ubs Group Ag

15.3K
Shares

$762
0.0% of portfolio

View Full List

About NRX PHARMACEUTICALS INC WT EXP

Ticker NRXPW
Sector Healthcare
Industry Biotechnology

More about NRXPW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account